PolyPeptide Group AG (0AAJ.L)
0AAJ.L Stock Price Chart
Explore PolyPeptide Group AG interactive price chart. Choose custom timeframes to analyze 0AAJ.L price movements and trends.
0AAJ.L Company Profile
Discover essential business fundamentals and corporate details for PolyPeptide Group AG (0AAJ.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Nov 2021
Employees
1.36K
Website
https://www.polypeptide.comCEO
Juan Jose Gonzalez
Description
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
0AAJ.L Financial Timeline
Browse a chronological timeline of PolyPeptide Group AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2025
Earnings released on 11 Mar 2025
Revenue for the quarter reached CHF 189.64M, missing expectations by -4.04%.
Earnings released on 13 Aug 2024
EPS came in at -CHF 0.34 surpassing the estimated -CHF 0.68 by +50.48%, while revenue for the quarter reached CHF 130.64M, beating expectations by +1.16%.
Earnings released on 12 Mar 2024
EPS came in at -CHF 0.49, while revenue for the quarter reached CHF 177.30M, beating expectations by +18.36%.
Earnings released on 30 Jun 2023
EPS came in at -CHF 1.02, while revenue for the quarter reached CHF 128.89M, beating expectations by +1.90%.
Earnings released on 31 Dec 2022
EPS came in at -CHF 0.08, while revenue for the quarter reached CHF 146.77M, missing expectations by -2.18%.
Earnings released on 30 Jun 2022
EPS came in at CHF 0.31 falling short of the estimated CHF 0.35 by -11.77%, while revenue for the quarter reached CHF 133.80M, missing expectations by -5.07%.
Dividend declared on 28 Apr 2022
A dividend of CHF 0.30 per share was announced, adjusted to CHF 0.30. The dividend was paid on 2 May 2022.
Earnings released on 31 Dec 2021
EPS came in at CHF 0.71, while revenue for the quarter reached CHF 152.30M, beating expectations by +8.36%.
Earnings released on 30 Jun 2021
EPS came in at CHF 0.87, while revenue for the quarter reached CHF 147.89M, beating expectations by +7.05%.
Earnings released on 31 Dec 2020
EPS came in at CHF 0.85, while revenue for the quarter reached CHF 146.81M.
0AAJ.L Stock Performance
Access detailed 0AAJ.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.